New Key Statistics Module, Z-Score and F-Score
NAS:CTSO Key Ratios
| Market Cap $ M | 49.77 |
| Enterprise Value $ M | 70.89 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.81 |
| Price/Sales | 1.41 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 33.00 |
| EPS (TTM) $ | -0.36 |
| Beneish M-Score | -2.58 |
| 10-y EBITDA Growth Rate % | -3.10 |
| 5-y EBITDA Growth Rate % | -7.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -3.78 |
| EV-to-EBITDA | -4.27 |
| PEG | -- |
| Shares Outstanding M | 54.68 |
| Net Margin (%) | -55.25 |
| Operating Margin % | -65.35 |
| Pre-tax Margin (%) | -57.66 |
| Quick Ratio | 1.58 |
| Current Ratio | 1.97 |
| ROA % (ttm) | -37.47 |
| ROE % (ttm) | -103.21 |
| ROIC % (ttm) | -66.04 |
| Dividend Yield % | -- |
| Altman Z-Score | -8.17 |
CTSO Number of Guru Trades
CTSO Volume of Guru Trades
Gurus Latest Trades with NAS:CTSO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CTSO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CytoSorbents Corp Insider Transactions
No Available Data
News about NAS:CTSO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers